(63) employed a CHK1 inhibitor and CRISPR knockout assays, demonstrating that ecDNA+ tumor cells exhibit heightened sensitivity to CHK1 inhibition, and CHK1 knockout was shown to induce ecDNA damage and subsequent cell death. The gene discussed is CHEK1; the disease is neoplasm.